Effects of biologics on vascular function and Atherosclerosis associated with Rheumatoid Arthritis

Research output: Conference contribution

47 Citations (Scopus)

Abstract

Endothelial dysfunction and accelerated atherosclerosis lead to increased cardiovascular morbidity and mortality in rheumatoid arthritis (RA). Sustained inflammation is a major risk factor. Apart from traditional vasculoprotective agents, biologics may also exert favorable effects on the vasculature. Indeed, tumor necrosis factor-α (TNF-α) inhibitors agents may transiently improve endothelial function. There are conflicting data regarding the effects of biologics on atherosclerosis and arterial stiffness. Infliximab stimulates the number and differentiation of endothelial progenitor cells that lead to vascular repair. There may be differences in the effects of TNF blockers on dyslipidemia, as long-term infliximab therapy may be proatherogenic, while some studies suggest that etanercept and adalimumab may exert beneficial effects on lipids. TNF blockers may decrease the incidence of cardiovascular events in RA. Preliminary data suggest that rituximab may also improve endothelial function and dyslipidemia. Further studies are needed to determine the net effects of biologics on the vasculature.

Original languageEnglish
Title of host publicationContemporary Challenges in Autoimmunity
PublisherBlackwell Publishing Inc.
Pages814-821
Number of pages8
ISBN (Print)9781573317627
DOIs
Publication statusPublished - szept. 2009

Publication series

NameAnnals of the New York Academy of Sciences
Volume1173
ISSN (Print)0077-8923
ISSN (Electronic)1749-6632

    Fingerprint

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • History and Philosophy of Science

Cite this

Kerekes, G., Soltész, P., Dér, H., Veres, K., Szabó, Z., Végvári, A., Shoenfeld, Y., & Szekanecz, Z. (2009). Effects of biologics on vascular function and Atherosclerosis associated with Rheumatoid Arthritis. In Contemporary Challenges in Autoimmunity (pp. 814-821). (Annals of the New York Academy of Sciences; Vol. 1173). Blackwell Publishing Inc.. https://doi.org/10.1111/j.1749-6632.2009.04645.x